Skip to main content

4 Result(s)

within Fu Jun Li Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

    Lauren K. Shea, Kazuhito Honjo, David T. Redden, Edlue Tabengwa… in Blood Cancer Journal (2019)

    Download PDF (537 KB) View Article

  2. No Access

    Article

    Calcitonin Gene-Related Peptide Is a Promising Marker in Ulcerative Colitis

    Assessment of the severity and extent of disease activity continues to present challenges for physicians in the treatment of ulcerative colitis. Standard markers that can objectively reflect disease activity a...

    Fu-Jun Li, Yi-You Zou, Yi Cui, YaNi Yin, George Guo… in Digestive Diseases and Sciences (2013)

  3. No Access

    Article

    Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals

    Interleukin-6 (IL-6) is a cytokine that regulates the proliferation of some tumor cells including multiple myeloma (MM). Ectopic expression of fibroblast growth factor receptor 3 (FGFR3) associated with the ch...

    Hideaki Ishikawa, Naohiro Tsuyama, Shangqin Liu, Saeid Abroun, Fu-Jun Li… in Oncogene (2005)

  4. No Access

    Article

    Growth mechanism of human myeloma cells by interleukin-6

    Human myeloma cells are heterogenous morphologically and phenotypically. Myeloma cells can be classified into at least 5 subpopulations; MPC-1-CD45+CD49e-, MPC-1-CD45-CD49e- immature myeloma cells, MPC-1+CD45-...

    Michio M. Kawano, Hideaki Ishikawa, Naohiro Tsuyama… in International Journal of Hematology (2002)